Manager or Director in projects supported by national organizations such as TUBITAK, DPT

• Overcoming Bortezomib Resistance by Targeting the PI3K Signaling Pathway in the Treatment of Multiple Myeloma
  (2022-2023) İzmir University of Economics - SRP (BAP)

• 1. Restoring the Therapy Efficiency for Imatinib Resistance in Ph+ Acute Lymphoblastic Leukemia by Drug Repurposing
  (2021-2022) TÜBİTAK